Pour-on NSAID for mastitis-induced fever in cattle OKed by FDAFebruary 22, 2023Merck Animal Health receives U.S. Food and Drug Administration (FDA) approval of expanded indication for BANAMINE TRANSDERMAL for the control of fever in cattle due to mastitis
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
Anti-nausea medication recalledJanuary 3, 2020The U.S. Food and Drug Administration (FDA) is alerting animal professionals about a recall on a drug commonly used to treat nausea and vomiting in cats.
FDA continues battle against large animal antiparasitic resistanceJanuary 2, 2020With 2020 underway, the U.S. Food and Drug Administration (FDA) says it is continuing its ongoing effort to address issues related to antiparasitic resistance in livestock and horses across the country.
Equine fever drug gets FDA approvalNovember 28, 2019Equine practitioners are now better equipped to treat patients experiencing pyrexia.
Third company issues pig ear recall over SalmonellaAugust 21, 2019A suspected connection between an outbreak of salmonellosis in humans and pig ear treats is forcing Dog Goods USA to issue a voluntary recall of some of its products.
Pig ears linked to human cases of salmonellosisAugust 2, 2019Pet owners across 33 states are being advised to dispose all pig ear treats, as the products are believed to be linked to an ongoing outbreak of multidrug-resistant Salmonella infections in humans.
Horse deaths linked to compounded EPM drugsJuly 25, 2019An unapproved, compounded drug is believed to be linked to a recent string of horse deaths in the U.S.
FDA approves ProHeart 12July 8, 2019The U.S. Food and Drug Administration’s (FDA’s) Center for Veterinary Medicine (CVM) has approved ProHeart 12 (moxidectin) extended release injectable suspension for dogs one year and older.
FDA updates on potential connection between certain diets and canine DCMJuly 3, 2019The U.S. Food and Drug Administration (FDA) is continuing its investigation into certain diets and a heightened risk of canine dilated cardiomyopathy (DCM), and for the first time, has named the brands most frequently linked to the condition.
Aratana Therapeutics' Nocita 10 ml gets FDA approvalJune 13, 2019Aratana Therapeutics announced the U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) has approved an additional vial size (10 ml) of Nocita. "Since its launch in 2016, Nocita has drastically changed veterinary multimodal pain management protocols because it safely and effectively controls pain in patients for up to 72 hours following certain canine and feline surgeries," says Aratana Therapeutics chief development officer, Ernst Heinen, DVM, PhD. "Ultimately, we believe a smaller vial size may allow for expanded use and improve the level of care veterinarians provide for certain painful surgeries." Nocita, which is currently available in a 20-ml vial size, is a local postoperative analgesia for cranial cruciate ligament surgery in dogs and a peripheral nerve block following owner-elected onychectomy (declawing) in cats. The smaller vial size is expected to be made commercially available in fall 2019.
